Mits Healthcare Private Limited

MENOPER 250MG Injection (Meropenem 250 mg Injection)

Description:
MENOPER 250MG Injection contains Meropenem 250 mg, a broad-spectrum carbapenem antibiotic that effectively targets a wide range of Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to the destruction of bacterial cells. MENOPER 250MG Injection is indicated for the treatment of moderate to severe bacterial infections, particularly those resistant to conventional antibiotics.

Highlighted Specifications:

• Composition: Meropenem 250 mg Injection

• Dosage Form: Injection (IV)

• Category: Broad-Spectrum Antibiotic / Carbapenem Class

• Indication: Moderate to Severe Bacterial Infections

• Strength: 250 mg

• Pack Type: Sterile Vial with WFI (if applicable)

• Storage Condition: Store below 25°C, protect from light and moisture

• Route of Administration: Intravenous (IV) under medical supervision

Key Benefits:

• Broad-spectrum efficacy against multidrug-resistant bacteria.

• Effective for both hospital-acquired and community-acquired infections.

• Provides rapid bacterial clearance and faster recovery.

• Excellent tissue penetration for systemic infections.

• Safe and well-tolerated in both adults and pediatric patients.

Indications:

• Respiratory tract infections (pneumonia, bronchitis)

• Urinary tract infections (complicated or hospital-acquired)

• Intra-abdominal and gastrointestinal infections

• Skin and soft tissue infections

• Septicemia, meningitis, and gynecological infections

MENOPER 125MG Injection (Meropenem 125 mg Injection)

Description:
MENOPER 125MG Injection contains Meropenem 125 mg, a broad-spectrum carbapenem antibiotic used for the treatment of mild to moderate bacterial infections. It works by inhibiting bacterial cell wall synthesis, leading to the rapid destruction of bacteria. MENOPER 125MG Injection is effective against a wide range of Gram-positive and Gram-negative microorganisms, including those resistant to other antibiotics.

Highlighted Specifications:

• Composition: Meropenem 125 mg Injection

• Dosage Form: Injection (IV)

• Category: Broad-Spectrum Antibiotic / Carbapenem Class

• Indication: Mild to Moderate Bacterial Infections

• Strength: 125 mg

• Pack Type: Sterile Vial with WFI (if applicable)

• Storage Condition: Store below 25°C, protect from light and moisture

• Route of Administration: Intravenous (IV) under medical supervision

Key Benefits:

• Provides broad-spectrum coverage against multidrug-resistant bacteria.

• Effective in the treatment of both community- and hospital-acquired infections.

• Rapid onset of action ensures early symptom relief and bacterial clearance.

• Excellent tissue penetration for better infection control.

• Safe and well-tolerated in pediatric and adult patients.

Indications:

• Respiratory tract infections (pneumonia, bronchitis)

• Urinary tract infections (complicated or hospital-acquired)

• Intra-abdominal and gastrointestinal infections

• Skin and soft tissue infections

• Septicemia, meningitis, and gynecological infections

Brand Name: GLUMIT 1200
Composition: Glutathione 1200 mg Injection
Category: Antioxidant / Skin Brightening / Detoxifying Agent

Description:
Glutathione 1200 mg Injection is a powerful antioxidant formulation designed to protect the body from harmful free radicals, support liver detoxification, and promote radiant, healthy skin. Glutathione, a naturally occurring tripeptide, plays a vital role in cellular defense and rejuvenation, helping to enhance overall wellness and restore skin vitality.

Indications:

• Skin lightening and brightening therapy

• Antioxidant support for anti-aging treatments

• Liver detoxification and cellular protection

• Adjuvant in chronic diseases related to oxidative stress

Key Benefits:

• Promotes brighter, more even-toned skin

• Helps neutralize free radicals and toxins

• Supports liver health and detoxification

• Improves overall cellular function and immune response

MENOPER 1GM Injection (Meropenem 1 g Injection)

Description:
MENOPER 1GM Injection contains Meropenem 1 g, a broad-spectrum carbapenem antibiotic effective against a wide range of Gram-positive and Gram-negative bacteria. It works by inhibiting bacterial cell wall synthesis, leading to rapid bacterial death. MENOPER 1GM is used for the treatment of severe bacterial infections, including those resistant to other antibiotics.

Highlighted Specifications:

• Composition: Meropenem 1 g Injection

• Dosage Form: Injection (IV)

• Category: Broad-Spectrum Antibiotic / Carbapenem Class

• Indication: Severe Bacterial Infections

• Strength: 1 g

• Pack Type: Sterile Vial with WFI (if applicable)

• Storage Condition: Store below 25°C, protect from light and moisture

• Route of Administration: Intravenous (IV) under medical supervision

Key Benefits:

• Provides broad-spectrum coverage against multidrug-resistant bacteria.

• Highly effective in treating hospital-acquired and complicated infections.

• Rapid onset of action with excellent tissue penetration.

• Reduces bacterial load and speeds up recovery.

• Well-tolerated with a strong safety profile in critically ill patients.

Indications:

• Respiratory tract infections (pneumonia, bronchitis)

• Urinary tract infections (complicated or hospital-acquired)

• Intra-abdominal infections

• Skin and soft tissue infections

• Septicemia, meningitis, and gynecological infections

GRANIMAX Injection (Granisetron Injection I.P.)

Description:
GRANIMAX Injection contains Granisetron I.P., a selective 5-HT₃ receptor antagonist used to prevent and treat nausea and vomiting caused by chemotherapy, radiotherapy, and surgical procedures. It works by blocking serotonin receptors in the brain and gastrointestinal tract, effectively controlling both acute and delayed emesis.

Highlighted Specifications:

• Composition: Granisetron Injection I.P.

• Dosage Form: Injection (IV)

• Category: Antiemetic

• Indication: Chemotherapy- and Radiotherapy-Induced Nausea & Vomiting, Post-Operative Nausea

• Strength: As per I.P. standards (commonly 1 mg/ml or as prescribed)

• Pack Type: Sterile Ampoule/Vial

• Storage Condition: Store below 25°C, protect from light

• Route of Administration: Intravenous (IV)

Key Benefits:

• Effectively prevents nausea and vomiting caused by cancer therapy or surgery.

• Provides fast onset and long-lasting relief from emetic episodes.

• Well-tolerated with minimal side effects and excellent patient compliance.

• Enhances comfort and quality of life during chemotherapy or post-surgery recovery.

Indications:

• Chemotherapy-induced nausea and vomiting (CINV)

• Radiotherapy-induced nausea and vomiting (RINV)

• Post-operative nausea and vomiting (PONV)

Additional Information:

• Delivery Time: 3-4 days
• Packaging Details: 10*1ml

MIEPOLY-B 50000 UNIT Injection (Polymyxin B for Injection USP 500,000 Units)

Description:
MIEPOLY-B 50000 UNIT Injection contains Polymyxin B 500,000 Units, a potent antibiotic used for the treatment of severe infections caused by multidrug-resistant Gram-negative bacteria. It acts by disrupting the bacterial cell membrane, leading to leakage of cellular contents and bacterial death. This antibiotic is particularly effective in treating infections where other antibiotics have failed.

Highlighted Specifications:

• Composition: Polymyxin B for Injection USP 500,000 Units

• Dosage Form: Injection (IV/IM)

• Category: Antibacterial / Polymyxin Class

• Indication: Severe Gram-negative Bacterial Infections

• Strength: 500,000 Units

• Pack Type: Sterile Vial for Injection

• Storage Condition: Store below 25°C, protect from light and moisture

• Route of Administration: Intravenous (IV) or Intramuscular (IM) under medical supervision

Key Benefits:

• Highly effective against multidrug-resistant Gram-negative organisms.

• Useful in treating life-threatening infections where other antibiotics are ineffective.

• Rapid bactericidal action by damaging bacterial cell membranes.

• Provides broad-spectrum coverage for serious systemic infections.

• Proven safety and efficacy when used under medical supervision.

Indications:

• Septicemia and bloodstream infections

• Respiratory tract infections caused by Gram-negative bacteria

• Urinary tract infections (severe or hospital-acquired)

• Meningitis and central nervous system infections

• Wound, burn, and skin infections caused by resistant organisms

Dosage & Administration:
To be administered as directed by the physician. Can be given via intravenous (IV) infusion or intramuscular (IM) injection under strict medical supervision. Dosage may vary based on the severity of infection and patient condition.

Additional Information:

• Packaging Details: TABLET

Additional Information:

• Production Capacity: LEVOCARTINIE TABLETS 500 MG
• Packaging Details: TABLETS

EMIPIME TZ 1.125 Injection (Cefepime 1 g + Tazobactam 125 mg)

Description:
EMIPIME TZ 1.125 Injection is a powerful broad-spectrum antibiotic combination of Cefepime (a fourth-generation cephalosporin) and Tazobactam (a beta-lactamase inhibitor). This synergistic formulation effectively combats a wide range of bacterial infections by inhibiting bacterial cell wall synthesis and protecting the antibiotic from enzymatic degradation.

Additional Information:

• Delivery Time: WITH IN WEEK

HEPAMIT-LP Injection (L-Ornithine L-Aspartate Infusion Injection 1×10 ml)

Description:
HEPAMIT-LP Injection contains L-Ornithine L-Aspartate, a combination of essential amino acids that play a vital role in detoxifying ammonia and improving liver function. It helps in the regeneration of liver cells, enhances metabolism, and supports overall hepatic health. This injection is highly effective in managing liver disorders such as hepatic encephalopathy, fatty liver, and liver cirrhosis.

Highlighted Specifications:

• Composition: L-Ornithine L-Aspartate Infusion Injection

• Dosage Form: Injection (IV)

• Category: Hepatoprotective / Liver Detoxifier

• Indication: Liver Disorders and Hepatic Detoxification

• Strength: 1×10 ml

• Pack Type: Sterile Ampoule/Vial

• Storage Condition: Store below 25°C, protect from light and moisture

• Route of Administration: Intravenous (IV) infusion under medical supervision

Key Benefits:

• Detoxifies ammonia and supports healthy liver metabolism.

• Promotes regeneration of damaged liver cells.

• Helps in the management of hepatic encephalopathy and liver cirrhosis.

• Reduces symptoms like fatigue, nausea, and confusion associated with liver dysfunction.

• Improves overall energy levels and metabolic performance.

Indications:

• Hepatic encephalopathy

• Liver cirrhosis and hepatitis

• Fatty liver and alcoholic liver disease

• Hyperammonemia and general liver dysfunction

Dosage & Administration:
As directed by the physician. To be administered via slow intravenous (IV) infusion under medical supervision.

Storage:
Store in a cool, dry place below 25°C. Protect from light and moisture.

HEPAMIT-LP Injection (L-Ornithine L-Aspartate Infusion Injection 5×2 ml)

Description:
HEPAMIT-LP Injection contains L-Ornithine L-Aspartate, a combination of amino acids that enhances liver detoxification and regeneration. It supports the removal of excess ammonia, improves hepatic metabolism, and promotes the recovery of damaged liver cells. This injection is highly beneficial for patients suffering from hepatic encephalopathy, liver cirrhosis, and fatty liver disease.

Highlighted Specifications:

• Composition: L-Ornithine L-Aspartate Infusion Injection

• Dosage Form: Injection (IV)

• Category: Hepatoprotective / Liver Detoxifier

• Indication: Liver Disorders and Hepatic Detoxification

• Strength: 5×2 ml

• Pack Type: Sterile Ampoule/Vial

• Storage Condition: Store below 25°C, protect from light and moisture

• Route of Administration: Intravenous (IV) infusion under medical supervision

Key Benefits:

• Promotes liver detoxification by converting harmful ammonia into urea.

• Regenerates damaged liver tissues and restores normal liver function.

• Helps in the management of hepatic encephalopathy and chronic liver diseases.

• Improves energy levels and reduces symptoms like fatigue and mental confusion.

• Supports metabolic processes and enhances overall liver performance.

Indications:

• Liver cirrhosis and hepatitis

• Hepatic encephalopathy

• Fatty liver and alcoholic liver disease

• Hyperammonemia and other liver dysfunctions

Dosage & Administration:
As directed by the physician. To be administered via slow intravenous (IV) infusion under medical supervision.

Storage:
Store in a cool, dry place below 25°C. Protect from light and moisture.

Pack Size:
Available in 5×2 ml sterile injection pack.

MEFITAX Injection (Tranexamic Acid Injection I.P. 5×5 ml)

Description:
MEFITAX Injection contains Tranexamic Acid I.P., an antifibrinolytic agent that helps prevent and control excessive bleeding. It works by inhibiting the breakdown of blood clots, making it effective in managing bleeding associated with surgeries, trauma, dental procedures, and gynecological conditions such as menorrhagia.

Highlighted Specifications:

• Composition: Tranexamic Acid Injection I.P.

• Dosage Form: Injection (IV/IM)

• Category: Antifibrinolytic / Antihemorrhagic Agent

• Indication: Control and Prevention of Excessive Bleeding

• Strength: 5×5 ml

• Pack Type: Sterile Ampoule/Vial

• Storage Condition: Store below 25°C, protect from light and moisture

• Route of Administration: Intravenous (IV) or Intramuscular (IM) under medical supervision

Key Benefits:

• Prevents and reduces excessive bleeding in various medical and surgical conditions.

• Useful in managing menorrhagia (heavy menstrual bleeding) and post-operative hemorrhage.

• Controls bleeding during dental extraction or trauma.

• Helps stabilize blood clots and promotes faster recovery.

• Well-tolerated with a proven safety profile.

Indications:

• Surgical and post-surgical bleeding

• Dental procedures in patients with bleeding tendencies

• Gynecological bleeding (menorrhagia, metrorrhagia)

• Trauma-induced hemorrhage

• Epistaxis and hematuria

PREZONE-TZ 1.125 Injection (Cefoperazone 1 g + Tazobactam 125 mg)

Description:
PREZONE-TZ 1.125 Injection is a potent broad-spectrum antibiotic combination of Cefoperazone and Tazobactam. Cefoperazone, a third-generation cephalosporin, works by inhibiting bacterial cell wall synthesis, while Tazobactam, a beta-lactamase inhibitor, protects Cefoperazone from enzymatic degradation. Together, they deliver enhanced antibacterial action against a wide range of Gram-positive and Gram-negative bacteria.

Highlighted Specifications:

• Composition: Cefoperazone 1 g + Tazobactam 125 mg

• Dosage Form: Injection (IM/IV)

• Category: Broad-Spectrum Antibiotic

• Indication: Severe Bacterial Infections

• Strength: 1.125 g

• Pack Type: Sterile Vial with WFI (if applicable)

• Storage Condition: Store below 25°C, protected from light and moisture

• Route of Administration: Intravenous (IV) or Intramuscular (IM)

Key Benefits:

• Broad-spectrum coverage against both Gram-positive and Gram-negative bacteria.

• Effective against beta-lactamase-producing resistant bacterial strains.

• Provides rapid and sustained antibacterial action for serious infections.

• Reduces the risk of treatment failure in mixed or hospital-acquired infections.

Indications:

• Respiratory tract infections

• Urinary tract infections

• Skin and soft tissue infections

• Intra-abdominal infections

• Gynecological infections

• Septicemia and bone/joint infections

Dosage & Administration:
As directed by the physician. To be administered via intravenous (IV) or intramuscular (IM) route under medical supervision.

Additional Information:

• Delivery Time: WITH IN WEEK
• Packaging Details: Category: Broad-Spectrum Antibiotic Indication: Severe Bacterial Infections Strength: 1.125 g Pack Type: Sterile Vial with WFI

Additional Information:

• Packaging Details: 30 tabs

CT-BEST Injection (Citicoline Injection 250 mg/ml)

Description:
CT-BEST Injection contains Citicoline 250 mg/ml, a neuroprotective and nootropic agent that helps restore and repair nerve cells in the brain. It enhances brain metabolism, supports cognitive functions, and promotes recovery after stroke, head injury, or other neurological conditions.

Key Benefits:

• Aids in the regeneration of nerve membranes and restoration of brain function.

• Improves memory, concentration, and mental alertness.

• Supports faster recovery in cases of cerebral ischemia, trauma, and neurodegenerative disorders.

• Enhances communication between nerve cells for better brain performance.

Indications:

• Stroke (ischemic and hemorrhagic)

• Head trauma

• Cognitive impairment and memory disorders

• Alzheimer’s disease and Parkinson’s disease (as adjunct therapy)

Dosage & Administration:
As directed by the physician. To be administered via intramuscular (IM) or intravenous (IV) route under medical supervision.

Storage:
Store in a cool, dry place below 25°C. Protect from light.

Additional Information:

• Delivery Time: 3-4 DAYS
• Packaging Details: 1 2ML AMPULE OF 250 MG IN SINGLE UNIT PACKING